EUVIMEDEUVIMED entdecken
Open Access

Liposomal Doxorubicin Induces PD-L1-High Tumor-Associated Macrophages and Sensitizes Triple-Negative Breast Cancer to PD-L1 Blockade

Yu Zheng, Peng Zheng, Yidan Zheng, Zihan Xi, Tao Huang

Oncology Research · 2026

DOI: 10.32604/or.2026.087138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Yu Zheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Doxorubicin, Triple Negative Breast Neoplasms, B7-H1 Antigen, Tumor-Associated Macrophages. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Liposomal doxorubicin (L-DOX) may alter macrophage-mediated immune regulation in triple-negative breast cancer (TNBC), but its role in programmed death-ligand 1 (PD-L1)-associated immune escape remains unclear. This study aimed to determine whether L-DOX induces a macrophage-centered PD-L1 response and affects the efficacy of PD-L1 blockade in TNBC.

Methods

Public bulk and single-cell transcriptomic datasets, bone marrow-derived macrophage models, CD8+ T-cell co-culture assays, promoter-binding analyses, and syngeneic EO771 and 4T1 TNBC mouse models were used to examine PD-L1 regulation and immune function after L-DOX treatment.

Results

The principal findings were that L-DOX preferentially induced a PD-L1-high macrophage state and sensitized TNBC tumors to PD-L1 blockade. DOX-containing therapy was associated with PD-L1 upregulation enriched in tumor-associated macrophages, and L-DOX induced stronger macrophage PD-L1 expression than free DOX or taxane-based agents. Mechanistically, L-DOX accumulation triggered DNA damage-associated ATM-p53 and cGAS-STING signaling, leading to RELA/p65-dependent NF-κB activation and PD-L1 transcription. Functionally, L-DOX-conditioned macrophages suppressed CD8+ T-cell activation, proliferation, and tumor-cell killing, whereas PD-L1 blockade restored CD8+ effector function, promoted pro-inflammatory macrophage features, and improved tumor control in EO771 and 4T1 models compared with either monotherapy.

Conclusion

L-DOX induces a PD-L1-high macrophage state with immunosuppressive features that constrains antitumor T-cell responses. Combining L-DOX with PD-L1 blockade may provide a rational chemoimmunotherapy strategy for TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinTriple Negative Breast NeoplasmsB7-H1 AntigenTumor-Associated MacrophagesImmune Checkpoint InhibitorsAnimalsFemaleHumansMiceCell Line, TumorCD8-Positive T-LymphocytesPolyethylene Glycols

Stichwörter der Autor:innen

Liposomal doxorubicinneoadjuvant chemotherapyprogrammed death-ligand 1 (PD-L1)triple-negative breast cancertumor-associated macrophages

Substanzen

DoxorubicinB7-H1 Antigenliposomal doxorubicinCD274 protein, humanImmune Checkpoint InhibitorsPolyethylene Glycols

Autor:innen und Institutionen

  • Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Thyroid Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Zitieren

APA

Zheng, Y., Zheng, P., Zheng, Y., Xi, Z., & Huang, T. (2026). Liposomal Doxorubicin Induces PD-L1-High Tumor-Associated Macrophages and Sensitizes Triple-Negative Breast Cancer to PD-L1 Blockade. Oncology Research. https://doi.org/10.32604/or.2026.087138

Vancouver

Zheng Y, Zheng P, Zheng Y, Xi Z, Huang T. Liposomal Doxorubicin Induces PD-L1-High Tumor-Associated Macrophages and Sensitizes Triple-Negative Breast Cancer to PD-L1 Blockade. Oncology Research. 2026. doi:10.32604/or.2026.087138

BibTeX
@article{Zheng2026,
  author = {Zheng, Yu and Zheng, Peng and Zheng, Yidan and Xi, Zihan and Huang, Tao},
  title = {Liposomal Doxorubicin Induces PD-L1-High Tumor-Associated Macrophages and Sensitizes Triple-Negative Breast Cancer to PD-L1 Blockade},
  journal = {Oncology Research},
  year = {2026},
  doi = {10.32604/or.2026.087138}
}
Kostenlos starten →